Thyme Care
PrivateLast Round
Series E
Sep 2, 2026
Est. Valuation
$2B
Total Funding Raised
$399M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Thyme Care is a healthcare technology company that provides an oncology care platform to support cancer patients throughout their treatment journey with physician-guided nursing and resource specialists, enhancing access to quality care and actionable insights for early intervention.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Patient Engagement, Vertical SaaS, Medical AI
Business Model
B2B2C
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thyme Care Comparables
Compare Thyme Care with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atlas Oncology Partners | 78% | |
| Evolent Health | 77% | |
| OncoHealth | 76% | |
Thyme Care Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Sep 2, 2026 | ||||
| Series D | Sep 25, 2025 | ||||
| Debt | Jul 16, 2024 | ||||
| Series C | Jul 16, 2024 | ||||
| Series B | Aug 22, 2023 | ||||
Series A | Oct 5, 2021 |
Key People
Founding team and executive leadership
Thyme Care Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series C, Series E, Series B, Series A, Series D |
| Town Hall Ventures | Series C, Series E, Series B, Series D |
| AlleyCorp | Series C, Series E, Series B, Series A, Series D |
| Frist Cressey Ventures | Series C, Series E, Series B, Series A, Series D |
| Texas Oncology | Series D |
| Foresite Capital | Series C, Series E, Series B, Series D |
| Morgan Health | Series D, Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
$125M round led by Morgan Health
- Jul 25, 2026
Monthly visitors increased 67% MoM.
Thyme Care Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Thyme Care's valuation, stock price, and market status.